a biotechnology company which engages in developing human antibodies for treating infectious diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with CDXS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then CDXS could also see price increases.
Ticker / NAME | Correlation To XFOR | 1D Price Change % | ||
---|---|---|---|---|
XFOR | 100% | -5.80% | ||
CDXS - XFOR | 37% Loosely correlated | -1.38% | ||
KROS - XFOR | 37% Loosely correlated | +5.38% | ||
COGT - XFOR | 35% Loosely correlated | +1.96% | ||
BEAM - XFOR | 34% Loosely correlated | -8.55% | ||
ABSI - XFOR | 33% Poorly correlated | -9.32% | ||
More |
Ticker / NAME | Correlation To XFOR | 1D Price Change % |
---|---|---|
XFOR | 100% | -5.80% |
biotechnology theme (248 stocks) | 33% Loosely correlated | +5.56% |
drugs theme (265 stocks) | 32% Poorly correlated | +5.37% |
diseases theme (42 stocks) | 26% Poorly correlated | +1.03% |
human theme (15 stocks) | 16% Poorly correlated | +1.59% |